CREDIT SUISSE AG/ - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 141 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$476,000
-24.3%
140,056
-16.3%
0.00%
-100.0%
Q2 2018$629,000
-8.3%
167,260
-0.5%
0.00%0.0%
Q1 2018$686,000
+18.7%
168,021
+35.2%
0.00%0.0%
Q4 2017$578,000
-32.6%
124,315
+2.9%
0.00%0.0%
Q3 2017$858,000
+37.5%
120,870
+40.1%
0.00%0.0%
Q2 2017$624,000
-39.1%
86,294
-48.2%
0.00%0.0%
Q1 2017$1,025,000
+124.3%
166,497
+113.2%
0.00%
Q4 2016$457,000
+72.5%
78,086
+56.5%
0.00%
Q3 2016$265,000
-69.0%
49,891
-61.4%
0.00%
-100.0%
Q2 2016$856,000
+21.1%
129,319
-14.6%
0.00%0.0%
Q1 2016$707,000
+19.0%
151,426
+28.8%
0.00%0.0%
Q4 2015$594,000
+214.3%
117,551
+119.3%
0.00%
Q3 2015$189,000
-82.3%
53,594
-50.0%
0.00%
-100.0%
Q2 2015$1,069,000
+138.1%
107,179
+203.8%
0.00%
Q1 2015$449,000
-66.1%
35,274
-62.3%
0.00%
-100.0%
Q4 2014$1,323,000
+6.7%
93,536
+3.8%
0.00%0.0%
Q3 2014$1,240,000
-15.8%
90,139
-5.8%
0.00%0.0%
Q2 2014$1,472,000
-35.6%
95,714
-28.7%
0.00%
-50.0%
Q1 2014$2,286,000
+50.1%
134,193
+14.1%
0.00%
+100.0%
Q4 2013$1,523,000
-9.5%
117,633
-29.5%
0.00%
-50.0%
Q3 2013$1,683,000
+402.4%
166,812
+271.9%
0.00%
Q2 2013$335,000
-50.0%
44,860
-52.9%
0.00%
-100.0%
Q1 2013$670,00095,1610.00%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
Foresite Capital Management I, LLC 1,312,006$22,357,00015.70%
VHCP Management, LLC 1,000,273$17,045,0008.86%
HARVEY CAPITAL MANAGEMENT INC 915,800$15,605,0006.22%
Baupost Group 6,310,850$107,537,0002.60%
SECTORAL ASSET MANAGEMENT INC 3,537,590$60,281,0002.48%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 587,504$10,011,0002.31%
Knoll Capital Management, LLC 200,000$3,408,0001.76%
Camber Capital Management LP 1,250,000$21,300,0001.67%
NORTHPOINTE CAPITAL LLC 877,875$14,958,0001.52%
DAFNA Capital Management LLC 100,000$1,704,0001.46%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders